bioxceltherapeutics.comBioXcel Therapeutics Inc – BioXcel Therapeutics Inc

bioxceltherapeutics.com Profile

bioxceltherapeutics.com is a domain that was created on 2017-03-22,making it 7 years ago. It has several subdomains, such as ir.bioxceltherapeutics.com , among others.

Discover bioxceltherapeutics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

bioxceltherapeutics.com Information

HomePage size: 210.019 KB
Page Load Time: 0.865371 Seconds
Website IP Address: 20.49.104.33

bioxceltherapeutics.com Similar Website

Aratana Therapeutics Investor Overview
aratana.investorroom.com
Jobs at Spark Therapeutics
careers.sparktx.com
Avenue Therapeutics, Inc. (ATXI)
ir.avenuetx.com
Viridian Therapeutics, Inc. - Investors & Media
investors.viridiantherapeutics.com
Clinical Pharmacology and Therapeutics Jobs - American Society for Clinical Pharmacology and Therape
careers.ascpt.org
Investor Relations :: Checkpoint Therapeutics, Inc. (CKPT)
ir.checkpointtx.com
Investor Relations | TG Therapeutics, Inc.
ir.tgtherapeutics.com
Revance Therapeutics, Inc. - Investor Relations
investors.revance.com
Investors | PTC Therapeutics, Inc.
ir.ptcbio.com
Acorda Therapeutics Inc - Investors
ir.acorda.com
Investor Relations :: BioXcel Therapeutics, Inc. (BTAI)
ir.bioxceltherapeutics.com
Investors | Flexion Therapeutics, Inc.
ir.flexiontherapeutics.com
Mirati Therapeutics Inc. - Investor & Media Relations
ir.mirati.com
Edgewise Therapeutics, Inc. - Investor
investors.edgewisetx.com
Halozyme Therapeutics, Inc. - Investor
ir.halozyme.com

bioxceltherapeutics.com PopUrls

BioXcel Therapeutics: Investor Relations
https://ir.bioxceltherapeutics.com/
BioXcel Therapeutics
https://www.bioxceltherapeutics.com/
Sitemap – BioXcel Therapeutics Inc
https://www.bioxceltherapeutics.com/sitemap/
Careers – BioXcel Therapeutics Inc
https://www.bioxceltherapeutics.com/careers/
Home Staging – BioXcel Therapeutics Inc
https://bioxceltherapeutics.com/home-staging/
Disclaimer – BioXcel Therapeutics Inc
https://www.bioxceltherapeutics.com/disclaimer/
OnkosXcel Therapeutics
https://bioxceltherapeutics.com/onkosxcel-therapeutics/
Advisors
https://www.bioxceltherapeutics.com/advisors/
Overview – BioXcel Therapeutics Inc
https://www.bioxceltherapeutics.com/overview/
igalmi-pi.pdf
https://pi.bioxceltherapeutics.com/

bioxceltherapeutics.com DNS

A bioxceltherapeutics.com. 3600 IN A 20.49.104.33
MX bioxceltherapeutics.com. 600 IN MX 2 mx2-us1.ppe-hosted.com.
NS bioxceltherapeutics.com. 3600 IN NS ns69.domaincontrol.com.
TXT bioxceltherapeutics.com. 1800 IN TXT cpgjpgx89sw4t1zvjydh725bvfs3vrwr
SOA bioxceltherapeutics.com. 3600 IN SOA ns69.domaincontrol.com. dns.jomax.net. 2024031303 28800 7200 604800 600

bioxceltherapeutics.com Httpheader

Content-Type: text/html; charset=utf-8
Date: Tue, 14 May 2024 21:45:22 GMT
Server: Apache
Transfer-Encoding: chunked
Vary: Accept-Encoding
Strict-Transport-Security: max-age=63072000; includeSubDomains
X-Powered-By: PHP/7.4.33
Link: https://bioxceltherapeutics.com/wp-json/; rel="https://api.w.org/", https://bioxceltherapeutics.com/wp-json/wp/v2/pages/1317; rel="alternate"; type="application/json", https://bioxceltherapeutics.com/; rel=shortlink
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
Content-Security-Policy: "default-src self unsafe-inline https://seal.godaddy.com/images/3/en/siteseal_gd_3_h_d_m.gif data: *.onetrust.com *.google.com *.cookielaw.org *.googletagmanager.com *.googleapis.com *.google-analytics.com *.gstatic.com; script-src self unsafe-inline unsafe-eval https://player.vimeo.com/api/player.js https://seal.godaddy.com data: *.cloudflare.com *.cookielaw.org *.googletagmanager.com; style-src self unsafe-inline data: *.googleapis.com; style-src-elem self unsafe-inline data: *.googleapis.com; frame-src self unsafe-inline https://player.vimeo.com/ https://www.google.com/; img-src self unsafe-inline data: https://secure.gravatar.com/ https://cdn.cookielaw.org/ https://seal.godaddy.com/ https://library.elementor.com/ https://s.w.org/images/", X-Content-Type-Options: nosniff
Referrer-Policy: same-origin
Feature-Policy: "geolocation self;"

bioxceltherapeutics.com Meta Info

charset="utf-8"/
content="width=device-width, initial-scale=1" name="viewport"/
content="max-image-preview:large" name="robots"
content="WordPress 6.5.2" name="generator"
content="Elementor 3.19.2; features: e_optimized_assets_loading, e_optimized_css_loading, additional_custom_breakpoints, block_editor_assets_optimize, e_image_loading_optimization; settings: css_print_method-external, google_font-enabled, font_display-auto" name="generator"/
content="/wp-content/uploads/2021/09/favicon-32x32-1.png" name="msapplication-TileImage"

bioxceltherapeutics.com Ip Information

Ip Country: United States
City Name: Washington
Latitude: 38.7095
Longitude: -78.1539

bioxceltherapeutics.com Html To Plain Text

Investors & Media Contact Us Careers Menu Investors & Media Contact Us CareersOverview Executive Officers Board of Directors Advisors OnkosXcel Therapeutics AI-based Drug Re-innovation Our Products Our Pipeline Patients & Advocacy Expanded Access MenuOverview Executive Officers Board of Directors Advisors OnkosXcel Therapeutics AI-based Drug Re-innovation Our Products Our Pipeline Patients & Advocacy Expanded Access AI-based Drug Re-innovation BioXcel Therapeutics, Inc. is a biopharmaceutical company developing transformative medicines in neuroscience utilizing artificial intelligence. Innovative Medicine Backed by the Power of AI BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. Innovative Medicine Backed by the Power of AI BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. Our Approach to Drug Development Optimizes R&D economics Shortens development timelines Increases probability of success Latest News VIEW ALL NEWS May 09, 2024 BioXcel Therapeutics Reports First Quarter 2024 Financial Results VIEW RELEASE Apr 25, 2024 BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024 VIEW RELEASE Apr 24, 2024 BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting VIEW RELEASE VIEW ALL NEWS Stock Information BioXcel Therapeutics, Inc. May 14, 2024 04:00 PM MARKET/SYMBOL Nasdaq: BTAI PRICE 2.13 CHANGE -0.055 (-2.52%) EVENTS SIGN UP FOR EMAIL ALERTS Linkedin-in TwitterAI-based Drug Re-innovation Our Products Our Pipeline Patients & AdvocacyAI-based Drug Re-innovation Our Products Our Pipeline Patients & Advocacy Investors & Media Contact Us Careers Investors & Media Contact Us CareersAI-based Drug Re-innovation Our Products Our Pipeline Patients & AdvocacyAI-based Drug Re-innovation Our Products Our Pipeline Patients & Advocacy Investors & Media Contact Us Careers Investors & Media Contact Us Careers IGALMI is a trademark of BioXcel Therapeutics, Inc. All other trademarks are the properties of their respective owners. Copyright © 2024 BioXcel Therapeutics Inc. All Rights Reserved. Privacy Policy Disclaimer Sitemap Privacy Policy Disclaimer Sitemap All other trademarks are the properties of their respective owners. Copyright © 2023 BioXcel Therapeutics Inc. All Rights Reserved. Privacy Policy Disclaimer Sitemap Privacy Policy Disclaimer Sitemap Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use. Scroll to Top You are about to leave BioXcelTherapeutics.com BioXcel Therapeutics, Inc. is not responsible for the content presented on a third-party website. Continue Cancel You are about to leave BioXcelTherapeutics.com BioXcel Therapeutics, Inc. is not responsible for the content presented on a third-party website. Continue Cancel You are about to leave BioXcelTherapeutics.com BioXcel Therapeutics, Inc. is not responsible for the content presented on a third-party website. Continue Cancel You are about to leave BioXcelTherapeutics.com BioXcel Therapeutics, Inc. is not responsible for the content presented on a third-party website. Continue Cancel Welcome to Bioxcel Medical Affairs Are you a healthcare professional practicing in the United States? Cancel Confirm The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. This web site is intended to help healthcare professionals practicing in the US find scientifically balanced, evidence-based information about Bioxcel Therapeutics drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support...

bioxceltherapeutics.com Whois

Domain Name: BIOXCELTHERAPEUTICS.COM Registry Domain ID: 2107069920_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2024-03-23T11:02:35Z Creation Date: 2017-03-22T15:24:41Z Registry Expiry Date: 2025-03-22T15:24:41Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS69.DOMAINCONTROL.COM Name Server: NS70.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:25:07Z <<<